NCT05241912

Supernormal Oxygen Delivery for Patients With Severe Burns

Supernormal Oxygen Delivery for Patients With Severe Burns：A Randomized Controlled Trial

• Status: Unknown
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Guangzhou Red Cross Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.

Detailed description

This is a randomized double-blinded study to investigate the effect of control group and the goal-directed fluid therapy group on complications during surgery of the burn patients. The groups are designated as the control group and the oal-directed fluid therapy group to further evaluate significant differences in complications during the surgery.

Conditions

• Burn Surgery
• Dobutamine

Interventions

Type	Name	Description
DRUG	Dobutamine	administration of dobutamine 0.01 - 0.04 U/min after induction of anesthesia to maintain oxygen delivery

Timeline

• Start date: 2022-02-28
• Primary completion: 2023-06-01
• Completion: 2023-06-01
• First posted: 2022-02-16
• Last updated: 2022-02-16

Locations

1 site across 1 country: China